Background
COVID-19 is a novel disease that started at the sea food Wuhan market and continues to spread to evolve into a global pandemic. Our data have shown a significant increase P=**** in glucose level for Covid-19 induce diabetes in patients (COV-I-DM) who have contracted COVID-19, compared to the other group of patients (COV-NS) that have shown normal levels of blood glucose.
Material(s) and Method(s)
Patients: The study had started March 15, 2020, to July 15 and included 5000 patients; we focused on 500 patients that meet our requirements. We divided them into two groups; the first group (COV-DM) is represented the 100 patients that have diabetes and contracted COVID-19. The second group has included 400 patients, and we separated them into (COV-I-DM) is described the 72 patients predisposed to diabetes after they got infected by COVID-19. The second group includes 328 patients (COV-NS) infected with COVID-19 and managed to control their blood glucose at normal levels.
Age: men and women in various age groups have been included in our study. To organize the data, we segregated the men's and womens' patients into two age groups (35-50) years or (50-65) years.
Specimens: Blood has been taken from patients in our Thi Qar Specialized Diabetes, Endocrine, and Metabolism Center, Nassiriya, Thi-Qar, Iraq.
Result(s)
Glucose levels have dramatically increased in patients with COV-DM compared to the other patients who managed to keep their glucose at an average level. The highest glucose is 486 and A1C 13.3, while the minimum is 13.3 and 6 for glucose and A1C, respectively. On the other hand, the most elevated glucose and A1C for COV-NS are 136,6.3, respectively. In contrast, the lowest level is 63, 4 for glucose and A1C,
Conclusion(s)
Our data suggest that a small proportion of patients around 72 (18%) of the total of patients 400 included in the study, have developed diabetes mellitus due to COVID-19.